08/03/2017
ORPHAZYME RAISES EUR 14 MILLION TO FURTHER EXPAND ITS CLINICAL DEVELOPMENT PROGRAMME
Orphazyme ApS today announced the successful completion of a EUR 14M financing round. Two new investors, LSP and the ALS Investment Fund joins the investor syndicate comprising Kurma Partners, Idinvest Partners, Novo A/S, Sunstone Capital and Aescap Venture. [...]
